Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study

Author(s):: Reinders, M.E.J. (0000-0001-9543-567X); Fijter, J.W. de; Roelofs, H.; Bajema, I.M.; Vries, D.K. de; Schaapherder, A.F.; Claas, F.H.J. (0000-0003-4157-6201); Miert, P.P.M.C. van; Roelen, D.L.; Kooten, C. van (0000-0002-6257-0899); Fibbe, W.E. (0000-0001-8539-9011); Rabelink, T.J.

Published: 2013
Publication type: Article / Letter to editor

Mesenchymal stem cellsKidneyImmunosuppressionTransplantation

Date issued: 2013-02-28
Language: English
Is part of: Stem Cells Translational Medicine (2013), Vol. 2, no. 2, p. 107-111
hdl: 1887/99763
doi: 10.5966/sctm.2012-0114